Melatonin and estradiol effects on food intake, body weight, and leptin in ovariectomized rats

Maturitas

Volumn 58, Issue 1, 2007, Pages 91-101

  Sanchez Mateos, S ^a   Alonso Gonzalez, C ^a   Gonzalez, A ^a   Martinez Campa, C M ^a   Mediavilla, M D ^a   Cos, S ^a   Sanchez Barcelo, E J ^a  

^a UNIVERSITY OF CANTABRIA   (Spain)

Author keywords

Body weight; Food efficiency; Food intake; Leptin; Melatonin; Obesity

Indexed keywords

6 HYDROXYMELATONIN O SULFATE; CHOLESTEROL; DRINKING WATER; DRUG METABOLITE; ESTRADIOL; GLUCOSE; HIGH DENSITY LIPOPROTEIN; LEPTIN; LOW DENSITY LIPOPROTEIN; MELATONIN; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; BREAST CANCER; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; FOOD INTAKE; HORMONE ACTION; NONHUMAN; OBESITY; OVARIECTOMY; POSTMENOPAUSE; RAT; SLEEP; URINARY EXCRETION;

ANALYSIS OF VARIANCE; ANIMALS; BODY WEIGHT; CHOLESTEROL; DISEASE MODELS, ANIMAL; EATING; ESTRADIOL CONGENERS; FEMALE; LEPTIN; MELATONIN; OBESITY; OVARIECTOMY; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA; RATTUS;

EID: 34547932839     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2007.06.006     Document Type: Article

References (52)

1. Bray G.A. Risks of obesity. Endocrinol Metab Clin North Am 32 (2003) 787-804
2. Stallone DD. The influence of obesity and its treatment on the immune system. Nutr Rev 52 (1994) 37-50
3. Hulka B.S. Epidemiologic analysis of breast and gynecologic cancers. Prog Clin Biol Res 396 (1997) 17-29
4. Smith-Kirwin S.M., O'Connor D.M., Johnston J., Lancey E., Hassink S.G., and Funage V.L. Leptin expression in human mammary epithelial cells and breast milk. J Clin Endocrinol Metab 83 (1998) 1810-1813
5. Friedman J.M., and Halaas J.L. Leptin and the regulation of body weight in mammals. Nature 395 (1998) 763-770
6. Rose D.P., Gilhooly E.M., and Nixon D.W. Adverse effects of obesity on breast cancer prognosis, and biological action of leptin. Int J Oncol 21 (2002) 1285-1292
7. Rose D.P., Komninou D., and Stephenson G.D. Obesity adipocytokines, and insulin resistence in breast cancer. Obes Rev 5 (2004) 153-165
8. Dumitrescu R.G., and Cotarla I. Understanding breast cancer risk-where do we stand in 2005?. J Cell Mol Med 9 (2005) 208-221
9. Magoffin D.A., Weitsman S.R., Aagarwal S.K., and Jakimiuk A.J. Leptin regulation of aromatase activity in adipose stromal cells from regularly cycling women. Ginekol Pol 70 (1999) 1-7
10. Sierra-Honigmann M.R., Nath A.K., Murakami C., Garcia-Cardena G., Papapetropoulos A., Sessa W.C., Madge L.A., Schechner J.S., Schwabb M.B., Polverini P.J., and Flores-Riveros J.R. Biological action of leptin as an angiogenic factor. Science 281 (1998) 1683-1686
11. Pandi-Perumal S.R., Srinivasan V., Maestroni G.J.M., Cardinali D.P., Poeggeler B., Hardeland R., and Melatonin. Nature's most versatile biological signal?. FEBS J 273 (2006) 2813-2838
12. Bubenik G.A. Gastrointestinal melatonin: localization, function and clinical relevance. Dig Dis Sci 47 (2002) 2336-2348
13. Iguichi H., Kato K.I., and Ibayashi H. Age-dependent reduction in serum melatonin concentrations in healthy human subjects. J Clin Endocrinol Metab 55 (1982) 27-29
14. Waldhauser F., Weiszenbacher G., Tatzer E., Gisinger B., Waldhauser M., Schemper M., and Frisch H. Alterations in nocturnal serum melatonin levels in humans with growth and aging. J Clin Endocrinol Metab 66 (1988) 648-652
15. Waldhauser F., Kovács J., and Reiter E. Age-related changes in melatonin levels in humans and its potential consequences for sleep disorders. Exp Gerontol 33 (1998) 759-772
16. Zeitzer J.M., Daniels J.E., DuffY J.F., Klerman E.B., Shanahan T.L., Dijk D.J., and Czeisler C.A. Do plasma melatonin concentration decline with age?. Am J Med 107 (1999) 432-436
17. Kennaway D.J., Lushington K., Dawson D., Lack L., Van der Heuvel C., and Rogers N. Urinary 6-sulphatoxymelatonin excretion and aging: new results and a critical review of the literature. J Pineal Res 27 (1999) 210-220
18. Rasmussen D.D., Boldt B.M., Wilkinson C.W., Yellon S.M., and Matsumoto A.M. Daily melatonin administration at middle age suppresses male rat visceral fat, plama leptin, and plasma insulin to youthful levels. Endocrinology 140 (1999) 1009-1012
19. Cos S., and Sanchez-Barceló E.J. Melatonin and mammary pathological growth. Front Neuroendocrinol 21 (2000) 133-170
20. Sanchez-Barceló E.J., Cos S., Mediavilla M.D., Martínez-Campa C., González A., and Alonso-González C. Melatonin-estrogen interactions in breast cancer. J Pineal Res 38 (2005) 217-222
21. Cos S., Martínez-Campa C., Mediavilla M.D., and Sánchez-Barceló E.J. Melatonin modulates aromatase activity in MCF-7 human breast cancer cells. J Pineal Res 38 (2005) 136-142
22. Cos S., González A., Güezmes A., et al. Melatonin inhibits the growth of DMBA-induced mammary tumors by decreasing the local biosynthesis of estrogens through the modulation of aromatase activity. Int J Cancer 118 (2006) 274-278
23. Reiter R.J. Mechanisms of cancer inhibition by melatonin. J Pineal Res 37 (2004) 213-214
24. Zhdanova I.V., and Wurtman R.J. Efficacy of melatonin as a sleep-promoting agent. J Biol Rhythms 112 (1997) 644-650
25. Pandi-Perumal S.R., Zisapel N., Srinivasan V., and Cardinali D.P. Melatonin and sleep in aging population. Exp Gerontol 40 (2005) 911-925
26. Parry B.L., Fernando Martínez L., Maurer E.L., López A.M., Sorenson D., and Meliska C.J. Sleep, rhythms and women's mood. Part II. Menopause. Sleep Med Rev 10 (2006) 197-208
27. Guardiola-Lemaître B. Toxicology of melatonin. J Biol Rhythm 12 (1997) 697-706
28. Wade G.N., Gray J.M., and Bartness T.J. Gonadal influence in adiposity. Int J Obes Relat Metab Disord 9 (1985) 83-92
29. Shimomura K., Shimizu H., Tsuchiya T., Abe Y., Uehara Y., and Mori M. Is leptin a key factor which develops obesity by ovariectomy?. Endocrine J 49 (2002) 417-423
30. Meli R., Pacilio M., Raso G.M., Esposito E., Coppola A., Nasti A., Di Carlo C., Nappi C., and Di Carlo R. Estrogen and raloxifene modulate leptin and its receptor in hypothalamus and adipose tissue from ovariectomized rata. Endocrinology 145 (2004) 3115-3121
31. Gambacciani M., Ciaponi M., Cappagli B., Piaggesi L., De Simone L., Orlandi R., and Genazzani A.R. Body weight, body fat distribution, and hormonal replacement therapy in early post-menopausal women. J Clin Endocrinol Metab 82 (1997) 414-417
32. van Seumeren I. Weight gain and hormone replacement therapy: are women's fear justified?. Maturitas 34 (2000) 3-8
33. Nelson H.D., Humphrey L.L., Nygren P., Teutsch S.M., and Allan J.D. Postmenopausal hormone replacement therapy: scientific review. JAMA 288 (2002) 872-881
34. Norman R.J., Flight I.H., and Rees M.C. Oestrogen and progesterone hormone replacement therapy for peri-menopausal and post-menopausal woman: weight and body fat distribution. Cochrane Database Syst Rev 2 (2000) CD001018
35. Prunet-Marcassus B., Desbazeille M., Bros A., Louche K., Delagrange P., Renard P., Casteilla L., and Penicaud L. Melatonin reduces body weight gain in Sprague-Dawley rats with diet-induced obesity. Endocrinology 144 (2003) 5347-5352
36. Puchalski S.S., Green J.N., and Rasmussen D.D. Melatonin effects on rat body weight regulation in response to high-fat diet at middle age. Endocrine 21 (2003) 163-167
37. Kalsbeek A., Fliers E., Romijn J.A., La Fleur S.E., Wortel J., Bakker O., Endert E., and Buijs R.M. The suprachiasmatic nucleus generates the diurnal changes in plasma leptin levels. Endocrinology 142 (2001) 2677-2685
38. Rasmussen D.D., Mitton D.R., Larsen S.A., and Yellon S.M. Aging-dependent changes in the effect of daily melatonin supplementation on rat metabolic and behavioural responses. J Pineal Res 31 (2001) 89-94
39. Wolden-Hanson T., Mitton D.R., McCants R.L., et al. Daily melatonin administration to middle-aged male rats suppresses body weight, intraabdominal adiposity, and plasma leptin and insulin independent of food intake and total body fat. Endocrinology 141 (2000) 487-497
40. Canpolat S., Sandal S., and Yilmaz B. Effects of pinealectomy and exogenous melatonin on serum leptin levels in male rats. Eur J Pharmacol 428 (2001) 145-148
41. Baydas G., Gursu F., and Canpolat S. Effects of pinealectomy on circadian release pattern of leptin in male rat. Neuroendocrinol Lett 22 (2001) 449-452
42. Adam C.L., and Mercer J.G. Appetite regulation and seasonality: implications for obesity. Proc Nutr Soc 63 (2004) 413-419
43. Alonso-Vale M.I., Borges-Silva C.N., Anhe G.F., et al. Light/dark cycle-dependent metabolic changes in adipose tissue of pinealectomized rats. Horm Metab Res 36 (2004) 474-479
44. Mastronardi C.A., Walczewska A., Yu W.H., Karanth S., Parlow A.F., and McCann S.M. The possible role of prolactin in the circadian rhythm of leptin secretion in male rats. PSEBM 224 (2000) 152-158
45. Cagnacci A., Malmusi S., Zanni A., Arangino S., Cagnacci P., and Volpe A. Acute modifications in the levels of daytime melatonin do not influence leptin in postmenopausal women. J Pineal Res 33 (2002) 57-60
46. Sener G., Balkan J., Cevikbas U., Keyer-Uysal M., and Uysal M. Melatonin reduces colesterol accumulation and prooxidant state induced by high colesterol diet in the plasma, the liver and probably the aorta of C57BL/6J mice. J Pineal Res 36 (2004) 212-216
47. Wakatsuki A., Okatani Y., Ikenkque N., Kaneda C., and Fukaya T. Effects of short term melatonin administration on lipoprotein metabolism in normolipidemic postmenopausal women. Maturitas 20 (2001) 171-177
48. Fleur S.E. Daily rhythms in glucose metabolism: suprachiasmatic nucleus output to peripheral tissue. J Neuroendocrinol 15 (2003) 315-322
49. Balasubramaniam S., Szanto A., and Roach P.D. Circadian rhythm in hepatic low-density-lipoprotein (LDL)-receptor expression and plasma LDL levels. Biochem J 298 (1994) 39-43
50. Strandberg T.E., Tilvis R.S., and Miettinen T.A. Diurnal variations of plasma methyl steroids and cholesterol in the rat: relation to hepatic cholesterol synthesis. Lipids 19 (1984) 202-205
51. Mondola P., Gambardella P., Santangelo F., Santillo M.R., and Greco A.M. Circadian rhythms of lipid apolipoprotein pattern in adult fasted rats. Physiol Behav 58 (1995) 175-180
52. Maffei M., Halaas J., Ravussin E., Pratley J.R.E., Lee G.H., Zhang Y., Fel H., Kim S., Lallone R., Ranganathan S., Kern P.A., and Friedman M. Leptin levels in human and rodents: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1 (1995) 1155-1161